Drug approval is often a necessarily long course of action, but for cannabis there have been the extra hurdles of legal roadblocks, in addition to the problem in obtaining patent protections for organic compounds.Synthetic cannabinoids confer with a category of lab-produced substances which are chemically much like chemicals present in the cannabis